Dr. Feuerborn et al present an institutional protocol and retrospective review for patients treated with IV sotalol for atrial fibrillation/flutter at the University of Utah Hospital. The streamlined protocol was successfully implemented, and their initial experience suggests feasibility, safety, and tolerability while reducing hospitalization duration. https://pubmed.ncbi.nlm.nih.gov/36812336/